Skip to content

Genetic analyses did not establish that coffee lowers liver cancer risk

A review of Mendelian randomization studies found no statistically significant association between coffee consumption and hepatocellular carcinoma across the methods examined.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The combined genetic analyses did not demonstrate a statistically significant relationship between coffee consumption and hepatocellular carcinoma. This weakens the case for claiming a protective causal effect from this evidence, but it does not prove that coffee has no effect. The uncertainty interval allowed both lower and higher odds of the cancer outcome.

Keep in mind

This abstract-based account lacks participant characteristics, the coffee-exposure contrast, and follow-up durations. Results varied across studies, and the reported uncertainty prevents a firm conclusion that coffee either protects against or has no effect on this cancer.

THE RESULT, WITH CONTEXT

What researchers found

No statistically significant association

Hepatocellular carcinoma

Genetically informed coffee analyses; the exposure comparison and timeframe were not specified. The principal odds-ratio interval included both lower and higher odds.

Gut Liver, 2026 · Original source ↓

A causal question

The review used Mendelian randomization studies to investigate whether coffee consumption might causally influence this liver cancer. It combined genetically informed analyses, rather than reporting a trial that assigned people to drink coffee.

Why the null result matters

Different analytical methods all failed to identify a statistically significant association. However, consistency in statistical nonsignificance does not establish equivalence, particularly when estimates are imprecise and the review reports substantial variation among studies.

CHECK THE ORIGINAL

The original publication

Coffee and the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies.

Choi HB, Kim H, Yoo JJ et al.
Gut Liver · 2026

PubMed ID
40852740
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.